This was further validated by upregulated PD-L1 mRNA and protein expressions in MPE/MA-cells that harvested from patients with NSCLC, ovarian serous cystadenocarcinoma (OSC) and pancreatic cancer (PC). This evidence concerns the gene CD274 and pachyonychia congenita.